Cite

    Kothari, J. et al. (n.d.). Autologous stem cell transplantation for follicular lymphoma is of most benefit early in the disease course and can result in durable remissions, irrespective of prior rituximab exposure. British journal of haematology. pp. 334-340. [Online].